PCA3

The PCA3 urine test is becoming a useful test for the diagnosis of prostate cancer. See article below. Refer to the website www.PCA3.org for the most up-to-date information.

Cleveland Clinic To Use Progensa PCA3 Test For Prostate Cancer Screenings.

The Cleveland Plain Dealer (7/20, Townsend) reports that even as "the quest for a better, more accurate prostate cancer screening test continues," the Cleveland Clinic "is the latest of a dozen centers across the country to offer the Progensa PCA3 test," which is "one of the latest, more accurate, such tests." PCA3 detects the presence of the gene of the same name, "which shows up in urine only when a man has prostate cancer." The gene is found "in more than 90 percent of prostate cancer cases," the paper says. Over 30 men have received the test and "about half of those tests" have indicated the need "for a follow-up biopsy." Clinical trials for the test "have ended," and Gen-Probe Inc., one of the developers, is preparing to file its regulatory application with the FDA by fall.